M
M2M Med | Chorzow, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
MK-7240
MK-7240-001
Tulisokibart
LY4268989
KarXT
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disea...
Enrolling
Alzheimer Disease
Drug: Placebo
Drug: Xanomeline Enteric Capsule
The purpose of this protocol is to evaluate the efficacy of tulisokibart in participants with moderately to severely active ulcerative colitis. Study...
Active, not recruiting
Ulcerative Colitis
Drug: IV Placebo
Drug: SC Placebo
New
The main purpose of this study is to evaluate the safety and effectiveness of LY4268989 when compared to placebo in adult participants with moderatel...
Begins enrollment in 1 month
Ulcerative Colitis (UC)
Ulcerative Colitis, Active Severe
Drug: Placebo
Drug: LY4268989
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems